RxDoctor Payments Data

Brian Kerr, MD

Otolaryngology · Gainesville, FLNPI 1376587717

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 24.8% of the total. Reporting peaked in 2023 at $910 and has fallen 64.0% since, to $327 in 2025.

$3,509in general payments, 2019–2025

Across 125 payments — averaging $28.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$872
  • Sanofi$401
  • Inspire Medical Systems, Inc.$244
  • Phathom Pharmaceuticals, Inc.$243
  • Amgen$157
  • Optinose US, Inc.$140
  • plus $1K from 29 others
$625,001in ownership & investment interests, 2019–2025

Across 4 payments — averaging $156,250 each. An ownership or investment interest held by the physician or an immediate family member.

  • Novapproach Spine, LLC$625K

What the payments were for

  • Food & beverage$3,509100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,509 in reported general payments places this provider in the 70th percentile of 586 otolaryngology providers in Florida.

See all otolaryngology providers in Florida

Medicare billing

Part B allowed, 2024
$185,760
Medicare patients
889
Services billed
1,451

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth12$1,178
Azelastine Hcl20$1,072
Omeprazole104$1,023
Fluticasone Propionate57$790
Ipratropium Bromide33$787
Gabapentin61$776
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip45$519
Clotrimazole15$376
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav25$335
Prednisone71$235
Mupirocin36$214
Ciprofloxacin Hcl17$198
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen27$172
Fluconazole13$100
Methylprednisolone17$85

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →